Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

LB-100: Ph I data

January 13, 2017 8:28 PM UTC

An open-label, dose-escalation, U.S. Phase I trial in 20 evaluable patients with solid tumors showed that once-daily IV LB-100 on days 1-3 of each 21-day cycle led to 1 partial response in a patient w...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article